Oliver Freudenreich, MD

Oliver Freudenreich, MD, FACLP an Associate Professor of Psychiatry at Harvard Medical School and a Psychiatrist at Massachusetts General Hospital (MGH), serves as co-director of the MGH Psychosis Clinical and Research Program and directs the MGH Fellowship in Public and Community Psychiatry. His academic interest lies in the area of optimal psychopharmacological treatment for schizophrenia, including the development of innovative treatments and management of treatment-resistant psychosis. In addition to his clinical and clinical trial expertise in schizophrenia, Dr. Freudenreich provides psychiatric consultations for medically complex patients with serious mental illness and for diagnostically difficult cases with psychosis. He has published extensively in his areas of interest and has written a handbook on psychotic disorders; its second edition was published in 2020. Dr. Freudenreich teaches and speaks on a regular basis at international and national meetings. Recent awards include the MGH Department of Psychiatry Clinical Excellence Award and the 2022 Outstanding Psychiatrist Award for the Public Sector from the Massachusetts Psychiatric Society.

Education & Training

• Fellowship: Massachusetts General Hospital, Psychiatry, 2000
• Residency: Robert Wood Johnson Medical School, Psychiatry, 1999
• Internship: New Jersey Medical School GME-UMDNJ, Psychiatry, 1996
• Fellowship: Duke University Medical Center, Clinical Research, 1995
• Medical Education: University of Heidelberg Medical School, 1993

Board Certifications

• Psychiatry, American Board of Psychiatry and Neurology
• Psychosomatic Medicine, American Board of Psychiatry and Neurology

Languages Spoken

• German
• English

Age Group Treated

• Adults
• Geriatrics